STOCK TITAN

Doximity Inc Stock Price, News & Analysis

DOCS NYSE

Welcome to our dedicated page for Doximity news (Ticker: DOCS), a resource for investors and traders seeking the latest updates and insights on Doximity stock.

Doximity, Inc. (NYSE: DOCS) is a digital platform for U.S. medical professionals, and its news flow reflects both its role in healthcare technology and its status as a public company. The company describes itself as the leading digital platform for U.S. medical professionals, with a verified clinical membership that includes more than 80% of U.S. physicians across specialties and practice areas.

News about Doximity often centers on its financial results and guidance. The company regularly issues press releases announcing quarterly and annual results, detailing revenue, net income, operating cash flow, free cash flow, and non-GAAP measures such as adjusted EBITDA and non-GAAP net income. These updates also highlight trends in engagement across its newsfeed, workflow, and AI products.

Another key category of DOCS news involves product and platform developments. Doximity has reported rapid growth in its AI suite, including tools like AI Scribe and DoxGPT, and has announced new AI-powered clinical reference and search capabilities. The acquisition of Pathway Medical Inc., a company specializing in medical AI and evidence-based clinical reference, is an example of transaction-related news that expands its AI and clinical reference offerings.

Doximity also issues research-based news, such as its Physician Compensation Report, which uses survey data from physicians on its platform to examine compensation trends, gender pay gaps, reimbursement pressures, and workforce strain. Additional news items include announcements of upcoming earnings releases, participation in investor conferences, and governance or legal updates disclosed via Form 8-K filings.

Investors and healthcare professionals can use the DOCS news stream to follow earnings announcements, AI and workflow product updates, acquisitions, research reports, and corporate governance developments related to Doximity’s role in the U.S. healthcare and digital health landscape.

Rhea-AI Summary

Doximity will participate in a virtual fireside chat at Morgan Stanley's 19th Annual Global Healthcare Conference on September 9, 2021, at 5:00 p.m. ET. CFO Anna Bryson will represent the company during this important industry event. The session will be available via webcast on Doximity's investor relations website, ensuring accessibility for stakeholders. Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals, serving over 80% of physicians across various specialties, aiming to enhance productivity and healthcare delivery.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.42%
Tags
conferences
-
Rhea-AI Summary

Doximity, Inc. (DOCS) announced its fiscal Q1 2022 results, reporting a 100% year-over-year revenue increase to $72.7 million and net income of $26.3 million. The company achieved a 36% net income margin and a non-GAAP net income of $30.6 million (42% margin). Adjusted EBITDA soared 696% year-over-year to $31.2 million. Doximity ended the quarter with a strong cash position of $726.5 million following its IPO. The company forecasts Q2 revenue between $73 million and $74 million and full-year revenue guidance of $296.5 million to $299.5 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
33.02%
Tags
-
Rhea-AI Summary

Doximity, Inc. (NYSE: DOCS) is set to announce its financial results for Q1 fiscal 2022, ending June 30, 2021, after the market closes on August 10, 2021. The company will hold a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss these results. Doximity is a leading digital platform for U.S. medical professionals, boasting over 80% of U.S. physicians as members. The company's mission is to enhance doctors' productivity to improve patient care.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.87%
Tags
Rhea-AI Summary

Doximity, Inc. has priced its initial public offering (IPO) of 23.3 million shares of Class A common stock at $26.00 per share. The total gross proceeds to Doximity from the offering are projected to be approximately $494.3 million, excluding underwriting discounts and expenses. The offering includes 19 million shares sold by Doximity and 4.3 million shares from an existing stockholder. Trading under the ticker symbol 'DOCS' is set to begin on June 24, 2021, with the offering closing on June 28, 2021, pending customary conditions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary

Doximity, a leading digital platform for U.S. medical professionals, has launched the roadshow for its initial public offering (IPO) of 23,300,000 shares of Class A common stock. The offering comprises 19,010,750 shares from Doximity and 4,289,250 shares from an existing stockholder. The expected IPO price ranges from $20.00 to $23.00 per share, with an overallotment option for underwriters to purchase up to an additional 3,495,000 shares. Doximity's shares will be traded on the New York Stock Exchange under the ticker symbol "DOCS."

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags

FAQ

What is the current stock price of Doximity (DOCS)?

The current stock price of Doximity (DOCS) is $22.5 as of April 7, 2026.

What is the market cap of Doximity (DOCS)?

The market cap of Doximity (DOCS) is approximately 4.3B.